Type your tag names separated by a space and hit enter

Icosapent ethyl reduces risk of CV death in patients with CV disease, low LDL, and high triglycerides (REDUCE-IT)

Icosapent ethyl reduces risk of CV death in patients with CV disease, low LDL, and high triglycerides (REDUCE-IT) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

Slawson, David C., et al., editors. "Icosapent Ethyl Reduces Risk of CV Death in Patients With CV Disease, Low LDL, and High Triglycerides (REDUCE-IT)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314705/all/Icosapent_ethyl_reduces_risk_of_CV_death_in_patients_with_CV_disease__low_LDL__and_high_triglycerides__REDUCE_IT_.
Icosapent ethyl reduces risk of CV death in patients with CV disease, low LDL, and high triglycerides (REDUCE-IT). In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314705/all/Icosapent_ethyl_reduces_risk_of_CV_death_in_patients_with_CV_disease__low_LDL__and_high_triglycerides__REDUCE_IT_. Accessed March 21, 2019.
Icosapent ethyl reduces risk of CV death in patients with CV disease, low LDL, and high triglycerides (REDUCE-IT). (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314705/all/Icosapent_ethyl_reduces_risk_of_CV_death_in_patients_with_CV_disease__low_LDL__and_high_triglycerides__REDUCE_IT_
Icosapent Ethyl Reduces Risk of CV Death in Patients With CV Disease, Low LDL, and High Triglycerides (REDUCE-IT) [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314705/all/Icosapent_ethyl_reduces_risk_of_CV_death_in_patients_with_CV_disease__low_LDL__and_high_triglycerides__REDUCE_IT_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Icosapent ethyl reduces risk of CV death in patients with CV disease, low LDL, and high triglycerides (REDUCE-IT) ID - 1314705 ED - Slawson,David C, ED - Shaughnessy,Allen F, ED - Ebell,Mark H, ED - Barry,Henry, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314705/all/Icosapent_ethyl_reduces_risk_of_CV_death_in_patients_with_CV_disease__low_LDL__and_high_triglycerides__REDUCE_IT_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -